"Health data represents one of the most valuable types of personal data available to companies, whether this be for the training of AI (it is worth noting that the AI health care market is estimated to reach a value of around $187bn by 2030, the development of digital health technology (such as wearables, estimated to be valued at around $76bn by 2030) or informing advertising strategy"
"These actions are not only impactful for affected data subjects, but are gaining popularity among commercial law firms and litigation investors, who view the cases as lucrative investment opportunities given the huge amounts of money companies may have to pay when they lose, a portion of which is typically given to the lawyers or investors supporting the affected data subjects."
Health data ranks among the most valuable types of personal data for companies, fueling AI training, digital health technologies and targeted advertising. The AI health care market is projected to reach about $187bn by 2030 and wearables around $76bn, while pregnancy data can be over 200 times more valuable to advertisers than age, gender or location. Corporate control over sensitive health data and rapid industry growth make regulatory or individual action difficult, leaving data subjects feeling powerless. Class actions in the US have emerged as a legal route for collective redress against exploitation of health data. Commercial firms and litigation investors increasingly pursue these cases because potentially very high damages can compel companies to change behavior.
Read at Privacy International
Unable to calculate read time
Collection
[
|
...
]